• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Hexindai Inc. (Amendment)

    7/23/21 4:30:21 PM ET
    $HX
    Finance: Consumer Services
    Finance
    Get the next $HX alert in real time by email
    SC 13G/A 1 tm2123129d1_sc13ga.htm SC 13G/A

     

      UNITED STATES  
      SECURITIES AND EXCHANGE COMMISSION  
      Washington, D.C. 20549  

     

    SCHEDULE 13G

     

    Under the Securities Exchange Act of 1934
    (Amendment No. 3)*

     

    Xiaobai Maimai Inc.

    (Name of Issuer)

     

    Ordinary Shares

    (Title of Class of Securities)

     

    98422P108

    (CUSIP Number)

     

    July 13, 2021

    (Date of Event Which Requires Filing of this Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

    ¨ Rule 13d-1(b)
    ¨ Rule 13d-1(c)
    x Rule 13d-1(d)

     

    *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

     

    The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes)

     

     

     

     

    CUSIP No. 98422P108 SCHEDULE 13G  

     

    1

    Name of Reporting Persons
    I.R.S. Identification Nos. of Above Persons (Entities Only)

    Xiaobo An

    2

    Check the Appropriate Box if a Member of a Group (See Instructions)

     

    (a)  ¨

     

    (b)  ¨

    3 SEC Use Only
    4 Citizenship or Place of Organization
    People’s Republic of China

    Number of
    Shares
    Beneficially
    Owned by
    Each
    Reporting
    Person With
    5 Sole Voting Power
    0 (See Item 4)
    6 Shared Voting Power
    0
    7 Sole Dispositive Power
    0 (See Item 4)
    8 Shared Dispositive Power
    0

    9 Aggregate Amount Beneficially Owned by Each Reporting Person
    0 (See Item 4)
    10 Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  ¨
    11 Percent of Class Represented by Amount in Row (9)
    0% (See Item 4)
    12 Type of Reporting Person (See Instructions)
    IN

     

    2

     

     

    CUSIP No. 98422P108 SCHEDULE 13G  

     

    1

    Name of Reporting Persons
    I.R.S. Identification Nos. of Above Persons (Entities Only)

    Hexin Holding Limited

    2

    Check the Appropriate Box if a Member of a Group (See Instructions)

     

    (a)  ¨

     

    (b)  ¨

    3 SEC Use Only
    4 Citizenship or Place of Organization
    British Virgin Islands

    Number of
    Shares
    Beneficially
    Owned by
    Each
    Reporting
    Person With
    5 Sole Voting Power
    0 (See Item 4)
    6 Shared Voting Power
    0
    7 Sole Dispositive Power
    0 (See Item 4)
    8 Shared Dispositive Power
    0

    9 Aggregate Amount Beneficially Owned by Each Reporting Person
    0 (See Item 4)
    10 Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  ¨
    11 Percent of Class Represented by Amount in Row (9)
    0% (See Item 4)
    12 Type of Reporting Person (See Instructions)
    CO

     

    3

     

     

    CUSIP No. 98422P108 SCHEDULE 13G  

     

    Item 1.
      (a) Name of Issuer:
    Xiaobai Maimai Inc. (the “Issuer”)
      (b) Address of Issuer’s Principal Executive Offices:
    Room 515, Floor 5, Jia No. 92-4 to 24 Jianguo Road, Chaoyang District, Beijing 100020, People's Republic of China
     
    Item 2.
      (a)

    Name of Person Filing:
    (1)              Xiaobo An (“Mr. An”)

     

    (2)               Hexin Holding Limited (“Hexin Holding”)

     

    Mr. An and Hexin Holding (collectively, the “Filing Persons”) have entered into a Joint Filing Agreement, a copy of which is filed with this amendment to Schedule 13G as Exhibit 99.1. Pursuant to the Joint Filing Agreement, the Filing Persons have agreed to file this amendment to Schedule 13G jointly in accordance with the provisions of Rule 13d-1(k) under the Act.

      (b)

    Address of Principal Business Office, or if none, Residence:

    (1)              Mr. An: c/o Room 515, Floor 5, Jia No. 92-4 to 24 Jianguo Road, Chaoyang District, Beijing 1000020, People’s Republic of China

     

    (2)               Hexin Holding: NovaSage Chambers, Wickham’s Cay II, Road Town, Tortola, British Virgin Islands.

      (c)

    Citizenship:
    (1)              Mr. An: People’s Republic of China

     

    (2)               Hexin Holding: British Virgin Islands

      (d) Title of Class of Securities:
    Ordinary Shares
      (e) CUSIP Number:
    98422P108
     
    Item 3. If this statement is filed pursuant to Sections §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
      Not Applicable.

     

    4

     

     

    CUSIP No. 98422P108 SCHEDULE 13G  

     

    Item 4. Ownership.
    Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

     

                  Shared  Sole power to   
               Sole power  power to  dispose or to  Shared power
           Percent   to vote or  vote or  direct the  to dispose or
    Reporting  Amount beneficially   of   direct the  to direct  disposition  to direct the
    Person(1)  owned   class(1)   vote  the vote  of(1)  disposition of
    Mr. An   0    0%  0  0  0  0
    Hexin Holding   0    0%  0  0  0  0

     

     

     Notes:

    (1)     This percentage is based on 48,850,574 ordinary shares outstanding as of July 23, 2021.

     

    Item 5. Ownership of Five Percent or Less of a Class.
      This statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities. On July 13, 2021, Hexin Holding sold 31,980,800 ordinary shares at a price of $1.59 per share, for a total sale price of $16,949,824. The number of ordinary shares deemed beneficially owned by Hexin Holding decreased from 31,980,800 to 0. The number of shares deemed to be beneficially owned Mr. An also decreased from 31,980,800 to 0 accordingly.
     
    Item 6. Ownership of More than Five Percent on Behalf of Another Person.
      Not Applicable.
     
    Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.
      Not Applicable.
     
    Item 8. Identification and Classification of Members of the Group.
      Not Applicable.
     
    Item 9. Notice of Dissolution of Group.
      Not Applicable.
       
    Item 10. Certifications.
      Not Applicable.

     

    5

     

     

    SIGNATURE

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    Date: July 23, 2021

     

        /s/ Xiaobo An
        Xiaobo An
         
       
      Hexin Holding Limited
         
      By: /s/ Xiaobo An
        Name: Xiaobo An
        Title: Director

     

    6

     

     

    EXHIBITS INDEX

     

    EXHIBIT NO.   EXHIBITS
    A   Joint Filing Agreement

     

    7

     

    Get the next $HX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HX

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $HX
    SEC Filings

    View All

    SEC Form 424B3 filed by Hexindai Inc.

    424B3 - Xiaobai Maimai Inc. (0001702318) (Filer)

    12/17/21 11:59:56 AM ET
    $HX
    Finance: Consumer Services
    Finance

    SEC Form 6-K filed by Hexindai Inc.

    6-K - Xiaobai Maimai Inc. (0001702318) (Filer)

    12/15/21 8:30:19 AM ET
    $HX
    Finance: Consumer Services
    Finance

    SEC Form 6-K filed by Hexindai Inc.

    6-K - Xiaobai Maimai Inc. (0001702318) (Filer)

    12/7/21 4:30:18 PM ET
    $HX
    Finance: Consumer Services
    Finance

    $HX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Akso Health Group Announces Effective Date of Name Change and Ticker Symbol Change

    BEIJING, Dec. 16, 2021 /PRNewswire/ -- Akso Health Group ("Akso Health", the "Company" or "We") (NASDAQ:AHG), formerly known as Xiaobai Maimai Inc., today announced that the Company will update its name and ticker symbol on the Nasdaq Stock Market, effective at the start of trading on December 16, 2021 (the "Effective Date"). On the Effective Date, the Company's ADS and ordinary shares will be quoted under the new name "Akso Health Group" which was previously approved by the Company's shareholders (the "Name Change"), and the Company's ticker symbol will be updated to "AHG". Ms. Yilin Wang, Chairwoman and Chief Executive Officer of Akso Health, commented, "We are excited to align our Nasdaq

    12/16/21 6:00:00 AM ET
    $HX
    Finance: Consumer Services
    Finance

    Akso Health Group Reports Unaudited Financial Results for First Half of Fiscal Year 2022

    BEIJING, Dec. 15, 2021 /PRNewswire/ -- Akso Health Group (NASDAQ:AHG) ("Akso Health", the "Company" or "we"), formerly known as Xiaobai Maimai Inc., a social e-commerce platform in China, today announced its unaudited condensed consolidated financial results for the six months ended September 30, 2021. The Company amended the ratio of ADS and ordinary shares from one (1) ADS representing one (1) ordinary share to one (1) ADS representing three (3) ordinary shares, effective as of August 24, 2020. Fiscal year refers to the 12-month period ended March 31. First Half of Fiscal Year 2022 Highlights Number of Average Monthly Mobile Active Users[1] for the six months ended September 30, 2021 was 8

    12/15/21 6:00:00 AM ET
    $HX
    Finance: Consumer Services
    Finance

    Xiaobai Maimai Announces the Results of Annual General Meeting and Name Change

    BEIJING, Dec. 3, 2021 /PRNewswire/ -- Xiaobai Maimai Inc. (NASDAQ:HX) ("Xiaobai Maimai" or the "Company"), today announced that it held the 2021 annual general meeting of shareholders (the "AGM") at the Meeting Room, Futian Shangri-La, 4088 Yi Tian Road, Futian District, Shenzhen 518408, People's Republic of China, at 10:00 a.m. (Beijing Time) on December 3, 2021. At the AGM, holders of 71,057,650 ordinary shares (including ordinary shares represented by the Company's American Depositary Shares), out of the 71,478,550 ordinary shares issued and outstanding, were present in person or by proxy, and therefore constituted a quorum of more than one-third of the ordinary shares outstanding and ent

    12/3/21 4:10:00 PM ET
    $HX
    Finance: Consumer Services
    Finance

    $HX
    Leadership Updates

    Live Leadership Updates

    View All

    Akso Health Group Reports Unaudited Financial Results for First Half of Fiscal Year 2022

    BEIJING, Dec. 15, 2021 /PRNewswire/ -- Akso Health Group (NASDAQ:AHG) ("Akso Health", the "Company" or "we"), formerly known as Xiaobai Maimai Inc., a social e-commerce platform in China, today announced its unaudited condensed consolidated financial results for the six months ended September 30, 2021. The Company amended the ratio of ADS and ordinary shares from one (1) ADS representing one (1) ordinary share to one (1) ADS representing three (3) ordinary shares, effective as of August 24, 2020. Fiscal year refers to the 12-month period ended March 31. First Half of Fiscal Year 2022 Highlights Number of Average Monthly Mobile Active Users[1] for the six months ended September 30, 2021 was 8

    12/15/21 6:00:00 AM ET
    $HX
    Finance: Consumer Services
    Finance

    Xiaobai Maimai Announces the Results of Annual General Meeting and Name Change

    BEIJING, Dec. 3, 2021 /PRNewswire/ -- Xiaobai Maimai Inc. (NASDAQ:HX) ("Xiaobai Maimai" or the "Company"), today announced that it held the 2021 annual general meeting of shareholders (the "AGM") at the Meeting Room, Futian Shangri-La, 4088 Yi Tian Road, Futian District, Shenzhen 518408, People's Republic of China, at 10:00 a.m. (Beijing Time) on December 3, 2021. At the AGM, holders of 71,057,650 ordinary shares (including ordinary shares represented by the Company's American Depositary Shares), out of the 71,478,550 ordinary shares issued and outstanding, were present in person or by proxy, and therefore constituted a quorum of more than one-third of the ordinary shares outstanding and ent

    12/3/21 4:10:00 PM ET
    $HX
    Finance: Consumer Services
    Finance

    Xiaobai Maimai Appoints Dr. Yingxian Liu as Medical Consultant for We Health Limited

    BEIJING, Oct. 22, 2021 /PRNewswire/ -- Xiaobai Maimai Inc. (NASDAQ:HX) ("Xiaobai Maimai," the "Company," or "we"), today announced the appointment of Dr. Yingxian Liu as the medical consultant to the Company. Dr. Liu will work closely with management to develop the Company's cancer therapy and radiation oncology business by the Company's wholly-owned subsidiary, We Health Limited. Dr. Liu received his medical degree from Sun Yat-sen University of Medical Sciences in Guangzhou, China. He completed his pathology residency at North Shore University Hospital in Manhasset, New York. Dr. Liu completed his hematopathology fellowship at Albert Einstein College of Medicine at Montefiore Medical Cente

    10/22/21 8:00:00 AM ET
    $HX
    Finance: Consumer Services
    Finance

    $HX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D filed by Hexindai Inc.

    SC 13D - Xiaobai Maimai Inc. (0001702318) (Subject)

    8/2/21 4:30:19 PM ET
    $HX
    Finance: Consumer Services
    Finance

    SEC Form SC 13G/A filed by Hexindai Inc. (Amendment)

    SC 13G/A - Xiaobai Maimai Inc. (0001702318) (Subject)

    7/23/21 4:30:21 PM ET
    $HX
    Finance: Consumer Services
    Finance

    SEC Form SC 13G/A filed

    SC 13G/A - Xiaobai Maimai Inc. (0001702318) (Subject)

    2/5/21 7:02:02 AM ET
    $HX
    Finance: Consumer Services
    Finance